Brown & Brown
BRO
$70.54
-1.49%
Brown & Brown, Inc. is a diversified insurance agency and brokerage firm providing retail insurance, wholesale brokerage, and insurance program services across the U.S., U.K., and other regions. As one of the largest independent insurance intermediaries in the United States, it differentiates itself through a decentralized operating model and a strong focus on M&A-driven growth. The current investor narrative centers on the company's robust organic growth and strategic acquisitions, such as the recent purchase of American Adventure Insurance, which expands its dealer services division. However, the stock has faced significant volatility, with a 22.5% decline over the past year, prompting debate about its valuation and growth sustainability amid a challenging insurance pricing environment.…
BRO
Brown & Brown
$70.54
Related headlines
Investment Opinion: Should I buy BRO Today?
Based on the analysis, BRO is rated a Hold. The consensus recommendation is 'Hold' with an average target price of $76.44, implying 7.4% upside. The thesis is that the company's strong growth and high margins are offset by valuation concerns and integration risks, making the risk-reward balanced.
Supporting evidence includes: (1) revenue growth of 37.3% YoY, (2) forward PE of 14.8x versus trailing 23.4x, (3) gross margin of 87.7%, and (4) free cash flow of $1.475B. These metrics indicate a financially healthy company with growth potential, but the PS ratio of 4.15x is above industry averages, suggesting the market is pricing in perfection.
The biggest risks are acquisition integration, potential margin compression, and a slowdown in organic growth. If the forward PE compresses below 12x or revenue growth decelerates below 10%, the rating would be downgraded to Sell. Conversely, if the company demonstrates sustained organic growth and margin expansion, the rating could be upgraded to Buy. Overall, the stock is fairly valued relative to its growth, but not a bargain.
Sign up to view all
BRO 12-Month Price Forecast
The AI assessment is neutral, reflecting a balanced risk-reward profile. The company's strong growth and high margins are positive, but the elevated valuation and integration risks temper enthusiasm. The forward PE suggests potential upside if earnings growth materializes, but the stock's recent underperformance indicates market skepticism. To upgrade to bullish, we would need to see sustained organic growth above 15% and margin expansion. To downgrade to bearish, we would need to see a significant slowdown in growth or a major acquisition misstep.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brown & Brown's 12-month outlook, with a consensus price target around $76.44 and implied upside of +8.4% versus the current price.
Average Target
$76.44
0 analysts
Implied Upside
+8.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$56 - $90
Analyst target range
Brown & Brown is covered by 16 analysts, with a consensus recommendation of 'Hold' and a mean rating of 2.79 (where 1 is Strong Buy and 5 is Sell). The average price target is $76.44, implying a 7.4% upside from the current price of $71.18. The distribution includes 7 Buy, 6 Hold, and 3 Sell ratings, reflecting a cautious but not bearish sentiment. The high target of $90.00 suggests potential for 26.4% upside, while the low target of $56.00 implies a 21.3% downside, indicating significant uncertainty.
Bulls vs Bears: BRO Investment Factors
Brown & Brown presents a mixed picture: robust revenue growth and high margins are offset by a significant price decline and elevated valuation concerns. The bull case rests on strong organic growth and strategic M&A, while the bear case highlights integration risks and a stretched sales multiple. Currently, the bearish evidence is slightly stronger given the stock's underperformance and analyst caution, but the forward PE suggests potential value if earnings growth materializes. The key tension is whether the company can sustain its growth trajectory and expand margins to justify its valuation, or if acquisition-driven growth will falter, leading to further downside.
Bullish
- Strong Revenue Growth: Q1 2026 revenue surged 37.3% YoY to $1.901B, driven by organic growth and acquisitions. This marks a significant acceleration from prior quarters, with revenue up 52.2% over the last four quarters, indicating robust demand and successful M&A integration.
- High Gross Margin: Gross margin stands at 87.7%, reflecting the asset-light insurance brokerage model with strong pricing power. This high margin provides a solid foundation for profitability and cash generation.
- Attractive Forward Valuation: Forward PE of 14.8x is well below the trailing PE of 23.4x, implying the market expects ~58% earnings growth. This suggests the stock is reasonably priced relative to its growth prospects, especially compared to the broader market.
- Strategic M&A Expansion: The recent acquisition of American Adventure Insurance adds 1,500+ dealership relationships, expanding the dealer services division. This aligns with BRO's proven M&A strategy, which has historically driven growth and market share gains.
Bearish
- Significant Price Decline: The stock has fallen 22.5% over the past year, underperforming the S&P 500 by 43.9 percentage points. This sustained downtrend reflects investor concerns about valuation and growth sustainability, despite recent recovery.
- Elevated Valuation Metrics: PS ratio of 4.15x and EV/Sales of 4.65x are high relative to historical norms, suggesting the market is paying a premium. Even with forward PE of 14.8x, the stock is not cheap on a sales basis, limiting upside.
- Acquisition Integration Risks: The 37.3% revenue growth is partly acquisition-driven, which may not be sustainable. Integration costs and potential overpayment for deals could pressure margins and earnings, as seen in the Q4 2025 net margin drop to 15.8%.
- Analyst Caution: Consensus recommendation is 'Hold' with a mean rating of 2.79, and 3 out of 16 analysts rate it a Sell. The average target price of $76.44 implies only 7.4% upside, reflecting limited confidence in near-term appreciation.
BRO Technical Analysis
Brown & Brown's stock is in a recovery phase after a severe drawdown, currently trading at $71.18, which is 72.4% of its 52-week range (low $53.81, high $98.30). The 1-year price change is -22.5%, indicating a sustained downtrend over the long term, but the stock has rebounded strongly from its May 2026 lows. The current price sits 32.3% above the 52-week low but remains 27.6% below the 52-week high, suggesting the stock is in a mid-range recovery, not yet near overbought levels.
Beta
0.58
0.58x market volatility
Max Drawdown
-49.6%
Largest decline past year
52-Week Range
$54-$98
Price range past year
Annual Return
-25.8%
Cumulative gain past year
| Period | BRO Return | S&P 500 |
|---|---|---|
| 1m | +5.5% | +2.9% |
| 3m | +25.3% | +5.0% |
| 6m | +3.0% | +13.9% |
| 1y | -25.8% | +20.4% |
| ytd | -9.1% | +13.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRO Fundamental Analysis
Brown & Brown's revenue growth has been robust, with Q1 2026 revenue of $1.901 billion, up 37.3% year-over-year, driven by strong organic growth and acquisitions. The multi-quarter trend shows acceleration, with revenue rising from $1.249 billion in Q2 2025 to $1.901 billion in Q1 2026, a 52.2% increase over four quarters. The Retail segment contributed $1.21 billion (63.6% of total revenue) and Specialty Distribution $682 million, with both segments showing solid growth. This growth trajectory supports the company's expansion strategy, though it may be partly acquisition-driven, which could moderate as integration costs rise.
Quarterly Revenue
$1.9B
2026-03
Revenue YoY Growth
+37.3%
YoY Comparison
Gross Margin
52.3%
Latest Quarter
Free Cash Flow
$1.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRO Overvalued?
Given Brown & Brown's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 23.4x, while the forward PE is 14.8x, implying the market expects significant earnings growth (approximately 58% increase) over the next year. This gap suggests optimism about margin expansion and continued revenue growth. The PS ratio of 4.15x and EV/Sales of 4.65x are also elevated, but the forward PE is more reasonable, indicating that the market is pricing in a strong earnings recovery.
PE
23.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 17x~35x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a debt-to-equity ratio of 0.63, which is manageable but could increase with M&A activity. The company's net margin of 17.7% is solid, but Q4 2025 showed a dip to 15.8%, indicating potential volatility. Free cash flow of $1.475B provides a cushion, but high acquisition spending could strain liquidity if deals underperform. Revenue concentration in the Retail segment (63.6%) exposes the company to cyclical insurance demand, though diversification across segments mitigates this somewhat.
Market risks include valuation compression, as the stock trades at a premium PS ratio of 4.15x compared to historical averages. The beta of 0.581 suggests lower market correlation, but the stock has underperformed the S&P 500 by 43.9% over the past year, indicating company-specific issues. Competitive pressures from larger brokers like Marsh & McLennan could intensify, and regulatory changes in insurance could impact margins. The recent acquisition of American Adventure Insurance adds integration risk, which could distract management and lead to operational missteps.
In a worst-case scenario, if organic growth decelerates and acquisitions fail to deliver expected synergies, the stock could fall to its 52-week low of $53.81, representing a 24.4% downside from the current price of $71.18. This would be exacerbated by a broader market downturn, given the stock's high beta relative to its sector. The max drawdown of -49.97% highlights the potential for significant losses, and investors should be prepared for volatility.
FAQ
The key risks are: (1) acquisition integration risk, as the recent purchase of American Adventure Insurance may not deliver expected synergies, (2) valuation risk, with a PS ratio of 4.15x leaving little room for error, (3) competitive risk from larger brokers, and (4) macro risk, as a recession could reduce insurance demand. The most severe risk is a combination of these factors leading to a decline to the 52-week low of $53.81, a 24.4% downside. Investors should monitor organic growth and margin trends closely.
The 12-month forecast is mixed. In the base case (50% probability), the stock trades around $76.44, the analyst average target. In the bull case (25% probability), it could reach $90, driven by strong growth and successful integration. In the bear case (25% probability), it could fall to $56, if growth stalls. The most likely scenario is the base case, assuming the company maintains its growth trajectory and avoids major integration issues. The stock's current price of $71.18 suggests limited upside, but the forward PE indicates potential for earnings-driven gains.
BRO is fairly valued to slightly overvalued. The trailing PE of 23.4x is above the market average, but the forward PE of 14.8x suggests the market expects significant earnings growth. The PS ratio of 4.15x is high, indicating a premium for its growth. Compared to peers, BRO trades at a similar multiple, but its growth rate justifies a premium. The market is pricing in a 58% earnings increase, which is optimistic but not unrealistic given the company's track record. If earnings growth falls short, the stock could be considered overvalued.
BRO is a Hold, not a strong buy. The stock offers a 7.4% upside to the average analyst target of $76.44, but the risk-reward is balanced. The company's strong revenue growth of 37.3% and high gross margin of 87.7% are positives, but the elevated PS ratio of 4.15x and integration risks from recent acquisitions temper enthusiasm. For long-term investors with a horizon of 3-5 years, BRO could be a good addition if you believe in its M&A strategy and organic growth. However, for short-term traders, the stock's volatility and analyst caution suggest waiting for a better entry point.
BRO is more suitable for long-term investment. The company's growth strategy, high margins, and low beta (0.581) make it a stable compounder over time. However, the stock's recent volatility and analyst caution suggest it is not ideal for short-term trading. A minimum holding period of 3-5 years is recommended to allow the M&A strategy to play out and for earnings growth to justify the valuation. Short-term traders may find better opportunities elsewhere, given the limited upside to the average target.